Private Equity

Healthcare

KKR-backed Biosynth Carbosynth acquires vivitide

Biosynth Carbosynth, which is backed by KKR, has acquired vivitide, a provider of custom peptides and antibodies for the life sciences and biotech industry.

3 min read · 17 March 2022

PE-backed Forensic Access Group buys ASI

Forensic Access Group, which is backed by Limerston Capital, has acquired Analytical Services International Limited, a bioanalysis and toxicology laboratory.

3 min read · 17 March 2022

HGGC-backed Fullscript acquires Emerson Ecologics

Fullscript, a portfolio company of HGGC, has acquired Emerson Ecologics, a healthcare firm.

2 min read · 17 March 2022

HGGC's Fullscript acquires Emerson Ecologics as addition to health-technology platform

The combined business will now be reaching a combined 70,000 healthcare practitioners and over 5 million patients. 'Now we have a really large platform that is driving market growth within integrative health,' said HGGC’s Bill Conrad.

3 min read · 17 March 2022

EQT's $7.5bn acquisition of Baring Private Equity Asia began with a casual conversation about IPOs

"We're not buying the market, we're not buying the region, we're not buying an index," EQT CEO Christian Sinding told PE Hub. "We're buying a high-performing private equity firm that's been navigating this area for a long time."

6 min read · 16 March 2022

Odyssey-backed PPG buys M Squared Associates

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired M Squared Associates, a clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry.

3 min read · 16 March 2022

Thoma Bravo to back growth of Circle Cardiovascular Imaging

Circle Cardiovascular Imaging, a Calgary-based provider of cardiovascular imaging software solutions, agreed to a growth investment from US private equity firm Thoma Bravo.

4 min read · 16 March 2022

2seventy bio raises $170m in private placement

Cambridge, Massachusetts-based 2seventy bio Inc, a immuno-oncology cell therapy company, has inked a private placement of about $170 million.

4 min read · 16 March 2022

“Every disease is a finite puzzle," said Deerfield's Jim Flynn

“Every drug since 2010, was invented by a university and by partnering with over 20 large universities, we are teaming up with the source of innovation and hopefully that leads to a differentiated return," said Deerfield's Jim Flynn.

6 min read · 16 March 2022

Frontier invests in Burbank Dental Laboratory

Frontier Dental Superholdings, which is backed by O2 Investment Partners, has made an investment in California-based Burbank Dental Laboratory, a dental lab.

2 min read · 15 March 2022

Showing 2,451 to 2,460 of 5,676 results
1…245247…568